Sirolimus-associated pericardial effusion with cardiac tamponade and interstitial pneumonitis in a hematopoietic stem cell transplant recipient.
Pediatr Transplant
; 23(4): e13425, 2019 06.
Article
en En
| MEDLINE
| ID: mdl-31012209
Sirolimus, a mammalian target of rapamycin (mTOR) inhibitor, is a potent immunosuppressant that is increasingly used in prevention and treatment of graft-vs-host disease (GVHD) in allogeneic hematopoietic stem cell transplant (HSCT) patients. However, data regarding its adverse effects in HSCT patients remain limited. We describe an 18-year-old HSCT patient with a history of invasive fungal infection, who developed pericardial effusion with cardiac tamponade and interstitial pneumonitis while receiving sirolimus for GVHD prophylaxis. Our case illustrates potentially life-threatening complications of sirolimus use in allogeneic HSCT patients.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Derrame Pericárdico
/
Complicaciones Posoperatorias
/
Taponamiento Cardíaco
/
Enfermedades Pulmonares Intersticiales
/
Trasplante de Células Madre Hematopoyéticas
/
Sirolimus
/
Inmunosupresores
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Pediatr Transplant
Asunto de la revista:
PEDIATRIA
/
TRANSPLANTE
Año:
2019
Tipo del documento:
Article